These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
600 related items for PubMed ID: 29924960
1. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old. Pirtea L, Secosan C, Margan M, Moleriu L, Balint O, Grigoras D, Sas I, Horhat F, Jianu A, Ilina R. Bosn J Basic Med Sci; 2019 Nov 08; 19(4):336-341. PubMed ID: 29924960 [Abstract] [Full Text] [Related]
2. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H]. Wu Y, Zhao J, Hu J, Wu XW, Zhu LR. Zhonghua Fu Chan Ke Za Zhi; 2017 Nov 25; 52(11):734-739. PubMed ID: 29179267 [Abstract] [Full Text] [Related]
3. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M. Clin Cancer Res; 2012 Aug 01; 18(15):4154-62. PubMed ID: 22675168 [Abstract] [Full Text] [Related]
4. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial. Wright TC, Behrens CM, Ranger-Moore J, Rehm S, Sharma A, Stoler MH, Ridder R. Gynecol Oncol; 2017 Jan 01; 144(1):51-56. PubMed ID: 28094038 [Abstract] [Full Text] [Related]
5. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL). Frega A, Pavone M, Sesti F, Leone C, Bianchi P, Cozza G, Colombrino C, Lukic A, Marziani R, De Sanctis L, Delli Carpini G, Caserta D, Ciavattini A. Eur Rev Med Pharmacol Sci; 2019 Dec 01; 23(24):10672-10677. PubMed ID: 31858534 [Abstract] [Full Text] [Related]
6. Value of P16 expression in the triage of liquid-based cervical cytology with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions. Ma YY, Cheng XD, Zhou CY, Qiu LQ, Chen XD, Lü WG, Xie X. Chin Med J (Engl); 2011 Aug 01; 124(16):2443-7. PubMed ID: 21933584 [Abstract] [Full Text] [Related]
7. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R, PALMS Study Group. Cancer Cytopathol; 2015 Jun 01; 123(6):373-81. PubMed ID: 25891096 [Abstract] [Full Text] [Related]
8. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study. El-Zein M, Gotlieb W, Gilbert L, Hemmings R, Behr MA, Franco EL, STAIN-IT Study Group. Int J Cancer; 2021 Jan 15; 148(2):492-501. PubMed ID: 32781481 [Abstract] [Full Text] [Related]
9. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women. Jiang MY, Wu Z, Li T, Yu L, Zhang SK, Zhang X, Qu P, Sun P, Xi MR, Liu X, Liao G, Sun L, Zhang Y, Chen W, Qiao YL. Cancer Prev Res (Phila); 2020 Feb 15; 13(2):163-172. PubMed ID: 31871224 [Abstract] [Full Text] [Related]
10. Improved abnormal Pap smear triage using cervical cancer biomarkers. Killeen JL, Dye T, Grace C, Hiraoka M. J Low Genit Tract Dis; 2014 Jan 15; 18(1):1-7. PubMed ID: 23760145 [Abstract] [Full Text] [Related]
11. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+). Tay TKY, Lim KL, Hilmy MH, Thike AA, Goh ST, Song LH, Hwang JSG, Mantoo S. Malays J Pathol; 2017 Dec 15; 39(3):257-265. PubMed ID: 29279588 [Abstract] [Full Text] [Related]
12. Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study. Liu W, Gong J, Xu H, Zhang D, Xia N, Li H, Song K, Lv T, Chen Y, Diao Y, Jao J, Dai S, Zhao P, Yao Q. Diagn Cytopathol; 2020 Jul 15; 48(7):635-644. PubMed ID: 32275355 [Abstract] [Full Text] [Related]
13. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women. Aromseree S, Wongjumpa W, Ekalaksananan T, Temtanakitpaisan A, Kleebkaow P, Srisathaporn S, Tongchai P, Pientong C. Asian Pac J Cancer Prev; 2022 Oct 01; 23(10):3405-3411. PubMed ID: 36308365 [Abstract] [Full Text] [Related]
14. p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Schmidt D, Bergeron C, Denton KJ, Ridder R, European CINtec Cytology Study Group. Cancer Cytopathol; 2011 Jun 25; 119(3):158-66. PubMed ID: 21442767 [Abstract] [Full Text] [Related]
15. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening]. Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF. Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350 [Abstract] [Full Text] [Related]
16. HPV genotyping and p16÷Ki-67 dual staining in the detection of high-grade cervical lesion in patients with LSIL on Pap smear. Moleriu LC, Sas I, RaŢiu AC, Margan MM, Secoşan CA, Ilina RŞ, Horhat FG, Stana LG, Grigoraş D, Pirtea LC. Rom J Morphol Embryol; 2017 Nov 25; 58(2):433-437. PubMed ID: 28730227 [Abstract] [Full Text] [Related]
17. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)]. Zhan X, Wang S, Wu X, Qiu X, Li F, Zeng Y, Chen Z. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct 25; 34(10):937-941. PubMed ID: 30554588 [Abstract] [Full Text] [Related]
18. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program. Ovestad IT, Dalen I, Hansen E, Loge JL, Dybdahl BM, Dirdal MB, Moltu P, Berland JM. Cancer Cytopathol; 2017 Apr 25; 125(4):283-291. PubMed ID: 27918650 [Abstract] [Full Text] [Related]
19. p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population. Luttmer R, Dijkstra MG, Snijders PJ, Berkhof J, van Kemenade FJ, Rozendaal L, Helmerhorst TJ, Verheijen RH, Ter Harmsel WA, van Baal WM, Graziosi PG, Quint WG, Spruijt JW, van Dijken DK, Heideman DA, Meijer CJ. Mod Pathol; 2016 Aug 25; 29(8):870-8. PubMed ID: 27150161 [Abstract] [Full Text] [Related]
20. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data. Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, Balfoort-van der Meij GA, Ridder R, Snijders PJ, Meijer CJ. Int J Cancer; 2015 May 15; 136(10):2361-8. PubMed ID: 25345358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]